LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...

Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science ...

Aptar said that adding Voluntis to its stable would allow help it develop a new generation of DTX for pharmaceutical and biotech customers, as well as other healthcare stakeholders including ...

Digitalisation of health is one of Chiesi's core R&D objectives, and the alliance with Aptar isn't its first in the respiratory category, its largest therapeutic area accounting for €1.7 billion ...

The conference will open with a Welcome Cocktail Reception on the evening of Tuesday, May 6, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Estoril on Thursday, May 8.

Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online® are pleased to announce their co-organization of RDD® Europe 2025, which will be held in-person from Tuesday ...

Aptar was recognized for its actions to cut emissions, mitigate climate risks and further the low-carbon economy, based on the data reported by the Company through CDP’s 2024 corporate questionnaire.

CRYSTAL LAKE, Ill., February 27, 2025--(BUSINESS WIRE)--Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online ® are pleased to announce their co-organization of RDD ® Europe 2025 ...